Medical Subject Headings
MeSH Tree Structures - 2013
C04 - Neoplasms
- Neoplasms [C04]
- Cysts [C04.182]
- Arachnoid Cysts [C04.182.044]
- Bone Cysts [C04.182.089]
- Branchioma [C04.182.117]
- Breast Cyst [C04.182.156]
- Bronchogenic Cyst [C04.182.195]
- Chalazion [C04.182.197]
- Choledochal Cyst [C04.182.198]
- Colloid Cysts [C04.182.199]
- Dermoid Cyst [C04.182.201]
- Epidermal Cyst [C04.182.254]
- Esophageal Cyst [C04.182.281]
- Follicular Cyst [C04.182.300]
- Ganglion Cysts [C04.182.347]
- Lymphocele [C04.182.430]
- Mediastinal Cyst [C04.182.444]
- Mesenteric Cyst [C04.182.473]
- Mucocele [C04.182.511]
- Ovarian Cysts [C04.182.612]
- Pancreatic Cyst [C04.182.640]
- Parovarian Cyst [C04.182.668]
- Pilonidal Sinus [C04.182.710]
- Ranula [C04.182.766]
- Synovial Cyst [C04.182.867]
- Tarlov Cysts [C04.182.872]
- Thyroglossal Cyst [C04.182.902]
- Urachal Cyst [C04.182.946]
- Hamartoma [C04.445]
- Neoplasms by Histologic Type [C04.557]
- Histiocytic Disorders, Malignant [C04.557.227]
- Leukemia [C04.557.337]
- Enzootic Bovine Leukosis [C04.557.337.100]
- Leukemia, Experimental [C04.557.337.372]
- Leukemia, Feline [C04.557.337.385]
- Leukemia, Hairy Cell [C04.557.337.415]
- Leukemia, Lymphoid [C04.557.337.428]
- Leukemia, Mast-Cell [C04.557.337.440]
- Leukemia, Myeloid [C04.557.337.539]
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive [C04.557.337.539.250]
- Leukemia, Myeloid, Acute [C04.557.337.539.275]
- Leukemia, Basophilic, Acute [C04.557.337.539.275.125]
- Leukemia, Eosinophilic, Acute [C04.557.337.539.275.300]
- Leukemia, Erythroblastic, Acute [C04.557.337.539.275.325]
- Leukemia, Mast-Cell [C04.557.337.539.275.440]
- Leukemia, Megakaryoblastic, Acute [C04.557.337.539.275.450]
- Leukemia, Monocytic, Acute [C04.557.337.539.275.484]
- Leukemia, Promyelocytic, Acute [C04.557.337.539.275.700]
- Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative [C04.557.337.539.300]
- Leukemia, Myelomonocytic, Acute [C04.557.337.539.520]
- Leukemia, Myelomonocytic, Chronic [C04.557.337.539.522]
- Leukemia, Myelomonocytic, Juvenile [C04.557.337.539.525]
- Sarcoma, Myeloid [C04.557.337.539.775]
- Leukemia, Plasma Cell [C04.557.337.595]
- Leukemia, Radiation-Induced [C04.557.337.650]
- Lymphatic Vessel Tumors [C04.557.375]
- Lymphoma [C04.557.386]
- Composite Lymphoma [C04.557.386.150]
- Hodgkin Disease [C04.557.386.355]
- Immunoproliferative Small Intestinal Disease [C04.557.386.390]
- Lymphoma, Non-Hodgkin [C04.557.386.480]
- Burkitt Lymphoma [C04.557.386.480.100]
- Lymphoma, B-Cell [C04.557.386.480.150]
- Burkitt Lymphoma [C04.557.386.480.150.165]
- Lymphoma, AIDS-Related [C04.557.386.480.150.450]
- Lymphoma, B-Cell, Marginal Zone [C04.557.386.480.150.570]
- Lymphoma, Large B-Cell, Diffuse [C04.557.386.480.150.585]
- Lymphoma, Primary Effusion [C04.557.386.480.150.592]
- Lymphomatoid Granulomatosis [C04.557.386.480.150.600]
- Lymphoma, Follicular [C04.557.386.480.350]
- Lymphoma, Large-Cell, Anaplastic [C04.557.386.480.487]
- Lymphoma, Large-Cell, Immunoblastic [C04.557.386.480.493]
- Lymphoma, Mantle-Cell [C04.557.386.480.525]
- Lymphoma, T-Cell [C04.557.386.480.750]
- Neoplasms, Complex and Mixed [C04.557.435]
- Adenolymphoma [C04.557.435.075]
- Adenoma, Pleomorphic [C04.557.435.090]
- Adenomyoepithelioma [C04.557.435.108]
- Adenomyoma [C04.557.435.110]
- Adenosarcoma [C04.557.435.135]
- Carcinoma, Adenosquamous [C04.557.435.250]
- Carcinosarcoma [C04.557.435.290]
- Composite Lymphoma [C04.557.435.295]
- Hepatoblastoma [C04.557.435.380]
- Mesenchymoma [C04.557.435.500]
- Mixed Tumor, Malignant [C04.557.435.525]
- Mixed Tumor, Mesodermal [C04.557.435.530]
- Mixed Tumor, Mullerian [C04.557.435.540]
- Myoepithelioma [C04.557.435.585]
- Wilms Tumor [C04.557.435.595]
- Nephroma, Mesoblastic [C04.557.435.600]
- Pulmonary Blastoma [C04.557.435.675]
- Rhabdoid Tumor [C04.557.435.710]
- Sarcoma, Endometrial Stromal [C04.557.435.775]
- Thymoma [C04.557.435.850]
- Neoplasms, Connective and Soft Tissue [C04.557.450]
- Neoplasms, Adipose Tissue [C04.557.450.550]
- Neoplasms, Connective Tissue [C04.557.450.565]
- Chondroblastoma [C04.557.450.565.250]
- Chondroma [C04.557.450.565.265]
- Chondrosarcoma [C04.557.450.565.280]
- Endometrial Stromal Tumors [C04.557.450.565.325]
- Gastrointestinal Stromal Tumors [C04.557.450.565.370]
- Giant Cell Tumors [C04.557.450.565.380]
- Mastocytosis [C04.557.450.565.465]
- Myofibroma [C04.557.450.565.540]
- Myxoma [C04.557.450.565.550]
- Myxosarcoma [C04.557.450.565.560]
- Neoplasms, Bone Tissue [C04.557.450.565.575]
- Neoplasms, Fibrous Tissue [C04.557.450.565.590]
- Sarcoma, Clear Cell [C04.557.450.565.800]
- Sarcoma, Small Cell [C04.557.450.565.825]
- Sarcoma, Synovial [C04.557.450.565.835]
- Neoplasms, Muscle Tissue [C04.557.450.590]
- Perivascular Epithelioid Cell Neoplasms [C04.557.450.692]
- Sarcoma [C04.557.450.795]
- Adenosarcoma [C04.557.450.795.135]
- Carcinosarcoma [C04.557.450.795.290]
- Chondrosarcoma [C04.557.450.795.300]
- Desmoplastic Small Round Cell Tumor [C04.557.450.795.315]
- Endometrial Stromal Tumors [C04.557.450.795.332]
- Fibrosarcoma [C04.557.450.795.350]
- Hemangiosarcoma [C04.557.450.795.390]
- Histiocytoma, Malignant Fibrous [C04.557.450.795.400]
- Leiomyosarcoma [C04.557.450.795.455]
- Liposarcoma [C04.557.450.795.465]
- Lymphangiosarcoma [C04.557.450.795.480]
- Mixed Tumor, Mesodermal [C04.557.450.795.530]
- Myosarcoma [C04.557.450.795.550]
- Myxosarcoma [C04.557.450.795.560]
- Osteosarcoma [C04.557.450.795.620]
- Phyllodes Tumor [C04.557.450.795.650]
- Sarcoma, Alveolar Soft Part [C04.557.450.795.775]
- Sarcoma, Clear Cell [C04.557.450.795.800]
- Sarcoma, Experimental [C04.557.450.795.830]
- Sarcoma, Kaposi [C04.557.450.795.850]
- Sarcoma, Myeloid [C04.557.450.795.853]
- Sarcoma, Small Cell [C04.557.450.795.870]
- Sarcoma, Synovial [C04.557.450.795.875]
- Neoplasms, Germ Cell and Embryonal [C04.557.465]
- Carcinoma, Embryonal [C04.557.465.200]
- Chordoma [C04.557.465.220]
- Germinoma [C04.557.465.330]
- Gonadoblastoma [C04.557.465.420]
- Mesonephroma [C04.557.465.510]
- Neuroectodermal Tumors [C04.557.465.625]
- Craniopharyngioma [C04.557.465.625.200]
- Neoplasms, Neuroepithelial [C04.557.465.625.600]
- Ganglioneuroma [C04.557.465.625.600.355]
- Glioma [C04.557.465.625.600.380]
- Astrocytoma [C04.557.465.625.600.380.080]
- Ependymoma [C04.557.465.625.600.380.290]
- Ganglioglioma [C04.557.465.625.600.380.350]
- Gliosarcoma [C04.557.465.625.600.380.400]
- Medulloblastoma [C04.557.465.625.600.380.515]
- Oligodendroglioma [C04.557.465.625.600.380.590]
- Optic Nerve Glioma [C04.557.465.625.600.380.795]
- Neurocytoma [C04.557.465.625.600.580]
- Neuroectodermal Tumors, Primitive [C04.557.465.625.600.590]
- Pinealoma [C04.557.465.625.600.657]
- Retinoblastoma [C04.557.465.625.600.725]
- Neuroectodermal Tumor, Melanotic [C04.557.465.625.630]
- Neuroendocrine Tumors [C04.557.465.625.650]
- Adenoma, Acidophil [C04.557.465.625.650.025]
- Adenoma, Basophil [C04.557.465.625.650.075]
- Adenoma, Chromophobe [C04.557.465.625.650.095]
- Apudoma [C04.557.465.625.650.135]
- Carcinoid Tumor [C04.557.465.625.650.200]
- Carcinoma, Neuroendocrine [C04.557.465.625.650.240]
- Melanoma [C04.557.465.625.650.510]
- Neurilemmoma [C04.557.465.625.650.595]
- Paraganglioma [C04.557.465.625.650.700]
- Teratocarcinoma [C04.557.465.900]
- Teratoma [C04.557.465.910]
- Trophoblastic Neoplasms [C04.557.465.955]
- Neoplasms, Glandular and Epithelial [C04.557.470]
- Adenoma [C04.557.470.035]
- ACTH-Secreting Pituitary Adenoma [C04.557.470.035.012]
- Adenoma, Acidophil [C04.557.470.035.025]
- Adenoma, Basophil [C04.557.470.035.075]
- Adenoma, Bile Duct [C04.557.470.035.085]
- Adenoma, Chromophobe [C04.557.470.035.095]
- Adenoma, Islet Cell [C04.557.470.035.100]
- Adenoma, Liver Cell [C04.557.470.035.120]
- Adenoma, Oxyphilic [C04.557.470.035.140]
- Adenoma, Pleomorphic [C04.557.470.035.155]
- Adenoma, Sweat Gland [C04.557.470.035.175]
- Adenoma, Villous [C04.557.470.035.185]
- Adenomatoid Tumor [C04.557.470.035.200]
- Adenomatosis, Pulmonary [C04.557.470.035.210]
- Adenomatous Polyps [C04.557.470.035.215]
- Adrenal Rest Tumor [C04.557.470.035.232]
- Apudoma [C04.557.470.035.250]
- Cystadenoma [C04.557.470.035.320]
- Growth Hormone-Secreting Pituitary Adenoma [C04.557.470.035.415]
- Mesothelioma [C04.557.470.035.510]
- Prolactinoma [C04.557.470.035.625]
- Carcinoma [C04.557.470.200]
- Adenocarcinoma [C04.557.470.200.025]
- Adenocarcinoma, Bronchiolo-Alveolar [C04.557.470.200.025.030]
- Adenocarcinoma, Clear Cell [C04.557.470.200.025.045]
- Adenocarcinoma, Follicular [C04.557.470.200.025.060]
- Adenocarcinoma, Mucinous [C04.557.470.200.025.075]
- Adenocarcinoma, Papillary [C04.557.470.200.025.085]
- Adenocarcinoma, Scirrhous [C04.557.470.200.025.095]
- Adenocarcinoma, Sebaceous [C04.557.470.200.025.105]
- Adrenocortical Carcinoma [C04.557.470.200.025.152]
- Carcinoid Tumor [C04.557.470.200.025.200]
- Carcinoma, Acinar Cell [C04.557.470.200.025.215]
- Carcinoma, Adenoid Cystic [C04.557.470.200.025.220]
- Carcinoma, Ductal [C04.557.470.200.025.232]
- Carcinoma, Endometrioid [C04.557.470.200.025.240]
- Carcinoma, Hepatocellular [C04.557.470.200.025.255]
- Carcinoma, Intraductal, Noninfiltrating [C04.557.470.200.025.275]
- Carcinoma, Islet Cell [C04.557.470.200.025.290]
- Carcinoma, Lobular [C04.557.470.200.025.305]
- Carcinoma, Mucoepidermoid [C04.557.470.200.025.340]
- Carcinoma, Neuroendocrine [C04.557.470.200.025.370]
- Carcinoma, Renal Cell [C04.557.470.200.025.390]
- Carcinoma, Signet Ring Cell [C04.557.470.200.025.415]
- Carcinoma, Skin Appendage [C04.557.470.200.025.420]
- Cholangiocarcinoma [C04.557.470.200.025.450]
- Choriocarcinoma [C04.557.470.200.025.455]
- Cystadenocarcinoma [C04.557.470.200.025.480]
- Eccrine Porocarcinoma [C04.557.470.200.025.500]
- Klatskin's Tumor [C04.557.470.200.025.540]
- Paget Disease, Extramammary [C04.557.470.200.025.660]
- Pulmonary Adenomatosis, Ovine [C04.557.470.200.025.715]
- Carcinoma, Adenosquamous [C04.557.470.200.150]
- Carcinoma, Basal Cell [C04.557.470.200.165]
- Carcinoma, Basosquamous [C04.557.470.200.170]
- Carcinoma, Ehrlich Tumor [C04.557.470.200.200]
- Carcinoma, Giant Cell [C04.557.470.200.220]
- Carcinoma in Situ [C04.557.470.200.240]
- Carcinoma, Krebs 2 [C04.557.470.200.255]
- Carcinoma, Large Cell [C04.557.470.200.260]
- Carcinoma, Lewis Lung [C04.557.470.200.280]
- Carcinoma, Papillary [C04.557.470.200.360]
- Carcinoma, Small Cell [C04.557.470.200.380]
- Carcinoma, Squamous Cell [C04.557.470.200.400]
- Carcinoma, Transitional Cell [C04.557.470.200.430]
- Carcinoma, Verrucous [C04.557.470.200.450]
- Adenocarcinoma [C04.557.470.200.025]
- Neoplasms, Adnexal and Skin Appendage [C04.557.470.550]
- Neoplasms, Basal Cell [C04.557.470.565]
- Neoplasms, Cystic, Mucinous, and Serous [C04.557.470.590]
- Adenocarcinoma, Mucinous [C04.557.470.590.075]
- Carcinoma, Mucoepidermoid [C04.557.470.590.340]
- Carcinoma, Signet Ring Cell [C04.557.470.590.415]
- Cystadenocarcinoma [C04.557.470.590.480]
- Cystadenofibroma [C04.557.470.590.482]
- Cystadenoma [C04.557.470.590.485]
- Mucoepidermoid Tumor [C04.557.470.590.580]
- Pseudomyxoma Peritonei [C04.557.470.590.782]
- Neoplasms, Ductal, Lobular, and Medullary [C04.557.470.615]
- Neoplasms, Fibroepithelial [C04.557.470.625]
- Neoplasms, Mesothelial [C04.557.470.660]
- Neoplasms, Neuroepithelial [C04.557.470.670]
- Ganglioneuroma [C04.557.470.670.355]
- Glioma [C04.557.470.670.380]
- Neurocytoma [C04.557.470.670.580]
- Neuroectodermal Tumors, Primitive [C04.557.470.670.590]
- Pinealoma [C04.557.470.670.657]
- Retinoblastoma [C04.557.470.670.725]
- Neoplasms, Squamous Cell [C04.557.470.700]
- Adenoma [C04.557.470.035]
- Neoplasms, Gonadal Tissue [C04.557.475]
- Neoplasms, Nerve Tissue [C04.557.580]
- Meningioma [C04.557.580.520]
- Nerve Sheath Neoplasms [C04.557.580.600]
- Neuroectodermal Tumors [C04.557.580.625]
- Craniopharyngioma [C04.557.580.625.200]
- Neoplasms, Neuroepithelial [C04.557.580.625.600]
- Ganglioneuroma [C04.557.580.625.600.355]
- Glioma [C04.557.580.625.600.380]
- Astrocytoma [C04.557.580.625.600.380.080]
- Ependymoma [C04.557.580.625.600.380.290]
- Ganglioglioma [C04.557.580.625.600.380.350]
- Gliosarcoma [C04.557.580.625.600.380.400]
- Medulloblastoma [C04.557.580.625.600.380.515]
- Oligodendroglioma [C04.557.580.625.600.380.590]
- Optic Nerve Glioma [C04.557.580.625.600.380.795]
- Neurocytoma [C04.557.580.625.600.580]
- Neuroectodermal Tumors, Primitive [C04.557.580.625.600.590]
- Pinealoma [C04.557.580.625.600.657]
- Retinoblastoma [C04.557.580.625.600.725]
- Neuroectodermal Tumor, Melanotic [C04.557.580.625.630]
- Neuroendocrine Tumors [C04.557.580.625.650]
- Adenoma, Acidophil [C04.557.580.625.650.025]
- Adenoma, Basophil [C04.557.580.625.650.075]
- Adenoma, Chromophobe [C04.557.580.625.650.095]
- Apudoma [C04.557.580.625.650.135]
- Carcinoid Tumor [C04.557.580.625.650.200]
- Carcinoma, Neuroendocrine [C04.557.580.625.650.240]
- Melanoma [C04.557.580.625.650.510]
- Neurilemmoma [C04.557.580.625.650.595]
- Paraganglioma [C04.557.580.625.650.700]
- Neoplasms, Plasma Cell [C04.557.595]
- Neoplasms, Vascular Tissue [C04.557.645]
- Angiofibroma [C04.557.645.100]
- Angiokeratoma [C04.557.645.115]
- Glomus Tumor [C04.557.645.350]
- Hemangioma [C04.557.645.375]
- Hemangiopericytoma [C04.557.645.380]
- Hemangiosarcoma [C04.557.645.390]
- Meningioma [C04.557.645.520]
- Sarcoma, Kaposi [C04.557.645.750]
- Nevi and Melanomas [C04.557.665]
- Odontogenic Tumors [C04.557.695]
- Neoplasms by Site [C04.588]
- Abdominal Neoplasms [C04.588.033]
- Anal Gland Neoplasms [C04.588.083]
- Bone Neoplasms [C04.588.149]
- Breast Neoplasms [C04.588.180]
- Digestive System Neoplasms [C04.588.274]
- Biliary Tract Neoplasms [C04.588.274.120]
- Gastrointestinal Neoplasms [C04.588.274.476]
- Esophageal Neoplasms [C04.588.274.476.205]
- Intestinal Neoplasms [C04.588.274.476.411]
- Cecal Neoplasms [C04.588.274.476.411.184]
- Colorectal Neoplasms [C04.588.274.476.411.307]
- Duodenal Neoplasms [C04.588.274.476.411.445]
- Ileal Neoplasms [C04.588.274.476.411.501]
- Jejunal Neoplasms [C04.588.274.476.411.523]
- Stomach Neoplasms [C04.588.274.476.767]
- Liver Neoplasms [C04.588.274.623]
- Pancreatic Neoplasms [C04.588.274.761]
- Peritoneal Neoplasms [C04.588.274.780]
- Endocrine Gland Neoplasms [C04.588.322]
- Adrenal Gland Neoplasms [C04.588.322.078]
- Multiple Endocrine Neoplasia [C04.588.322.400]
- Ovarian Neoplasms [C04.588.322.455]
- Pancreatic Neoplasms [C04.588.322.475]
- Paraneoplastic Endocrine Syndromes [C04.588.322.490]
- Parathyroid Neoplasms [C04.588.322.525]
- Pituitary Neoplasms [C04.588.322.609]
- Testicular Neoplasms [C04.588.322.762]
- Thyroid Neoplasms [C04.588.322.894]
- Eye Neoplasms [C04.588.364]
- Head and Neck Neoplasms [C04.588.443]
- Esophageal Neoplasms [C04.588.443.353]
- Facial Neoplasms [C04.588.443.392]
- Mouth Neoplasms [C04.588.443.591]
- Otorhinolaryngologic Neoplasms [C04.588.443.665]
- Parathyroid Neoplasms [C04.588.443.680]
- Thyroid Neoplasms [C04.588.443.915]
- Tracheal Neoplasms [C04.588.443.925]
- Hematologic Neoplasms [C04.588.448]
- Mammary Neoplasms, Animal [C04.588.531]
- Nervous System Neoplasms [C04.588.614]
- Central Nervous System Neoplasms [C04.588.614.250]
- Brain Neoplasms [C04.588.614.250.195]
- Central Nervous System Cysts [C04.588.614.250.387]
- Meningeal Neoplasms [C04.588.614.250.580]
- Spinal Cord Neoplasms [C04.588.614.250.803]
- Cranial Nerve Neoplasms [C04.588.614.300]
- Paraneoplastic Syndromes, Nervous System [C04.588.614.550]
- Anti-N-Methyl-D-Aspartate Receptor Encephalitis [C04.588.614.550.112]
- Lambert-Eaton Myasthenic Syndrome [C04.588.614.550.225]
- Limbic Encephalitis [C04.588.614.550.450]
- Myelitis, Transverse [C04.588.614.550.550]
- Opsoclonus-Myoclonus Syndrome [C04.588.614.550.600]
- Paraneoplastic Cerebellar Degeneration [C04.588.614.550.650]
- Paraneoplastic Polyneuropathy [C04.588.614.550.700]
- Peripheral Nervous System Neoplasms [C04.588.614.596]
- Central Nervous System Neoplasms [C04.588.614.250]
- Pelvic Neoplasms [C04.588.699]
- Skin Neoplasms [C04.588.805]
- Soft Tissue Neoplasms [C04.588.839]
- Splenic Neoplasms [C04.588.842]
- Thoracic Neoplasms [C04.588.894]
- Heart Neoplasms [C04.588.894.309]
- Mediastinal Neoplasms [C04.588.894.479]
- Respiratory Tract Neoplasms [C04.588.894.797]
- Lung Neoplasms [C04.588.894.797.520]
- Pleural Neoplasms [C04.588.894.797.640]
- Tracheal Neoplasms [C04.588.894.797.760]
- Thymus Neoplasms [C04.588.894.949]
- Urogenital Neoplasms [C04.588.945]
- Genital Neoplasms, Female [C04.588.945.418]
- Genital Neoplasms, Male [C04.588.945.440]
- Urologic Neoplasms [C04.588.945.947]
- Venereal Tumors, Veterinary [C04.588.945.956]
- Neoplasms, Experimental [C04.619]
- Carcinoma 256, Walker [C04.619.045]
- Carcinoma, Brown-Pearce [C04.619.124]
- Carcinoma, Ehrlich Tumor [C04.619.169]
- Carcinoma, Krebs 2 [C04.619.214]
- Carcinoma, Lewis Lung [C04.619.230]
- Leukemia, Experimental [C04.619.531]
- Liver Neoplasms, Experimental [C04.619.540]
- Mammary Neoplasms, Experimental [C04.619.590]
- Melanoma, Experimental [C04.619.600]
- Sarcoma, Experimental [C04.619.857]
- Tumor Virus Infections [C04.619.935]
- Neoplasms, Hormone-Dependent [C04.626]
- Neoplasms, Multiple Primary [C04.651]
- Neoplasms, Post-Traumatic [C04.666]
- Neoplasms, Radiation-Induced [C04.682]
- Neoplasms, Second Primary [C04.692]
- Neoplastic Processes [C04.697]
- Neoplastic Syndromes, Hereditary [C04.700]
- Adenomatous Polyposis Coli [C04.700.100]
- Basal Cell Nevus Syndrome [C04.700.175]
- Birt-Hogg-Dube Syndrome [C04.700.212]
- Colorectal Neoplasms, Hereditary Nonpolyposis [C04.700.250]
- Dysplastic Nevus Syndrome [C04.700.305]
- Exostoses, Multiple Hereditary [C04.700.330]
- Hamartoma Syndrome, Multiple [C04.700.435]
- Hereditary Breast and Ovarian Cancer Syndrome [C04.700.517]
- Li-Fraumeni Syndrome [C04.700.600]
- Multiple Endocrine Neoplasia [C04.700.630]
- Tuberous Sclerosis [C04.700.632]
- Wilms Tumor [C04.700.635]
- Neurofibromatoses [C04.700.645]
- Peutz-Jeghers Syndrome [C04.700.705]
- Paraneoplastic Syndromes [C04.730]
- Paraneoplastic Endocrine Syndromes [C04.730.713]
- Paraneoplastic Syndromes, Nervous System [C04.730.856]
- Anti-N-Methyl-D-Aspartate Receptor Encephalitis [C04.730.856.112]
- Lambert-Eaton Myasthenic Syndrome [C04.730.856.225]
- Limbic Encephalitis [C04.730.856.437]
- Myelitis, Transverse [C04.730.856.543]
- Opsoclonus-Myoclonus Syndrome [C04.730.856.596]
- Paraneoplastic Cerebellar Degeneration [C04.730.856.650]
- Paraneoplastic Polyneuropathy [C04.730.856.700]
- Paraneoplastic Syndromes, Ocular [C04.730.900]
- Precancerous Conditions [C04.834]
- Pregnancy Complications, Neoplastic [C04.850]
- Tumor Virus Infections [C04.925]
- Cysts [C04.182]
Copyright, Privacy, Accessibility, Site Map, Viewers and Players
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act, NLM Customer Support
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act, NLM Customer Support
